SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

Alerts delivered via the electronic health record temporarily reduces unnecessary screening and treatment but does not create ...

Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...

The Royal Family has dramatically increased their number of engagements with King Charles leading the way - their output is ...

23. Dahiya D, Mackin C, Nigam PS. Studies on bioactivities of Manuka and regional varieties of honey for their potential use ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic ...

Pfizer's TALAPRO-2 study shows Talzenna + Xtandi significantly improves survival in mCRPC patients, with up to a 14-month OS ...